<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Sat, 18 Apr 2026 21:07:37 -0400--><rss version="2.0">
    <channel>
        <title>Mineralys Therapeutics, Inc. (MLYS) Press Releases</title>
        <link>https://ir.mineralystx.com/news-events/press-releases/rss</link>
        <description></description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/mineralystx/files/theme/images/logo-email.png</url>
                <title>Mineralys Therapeutics, Inc. Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[Mineralys Therapeutics Appoints Jeffrey A. Munsie as Chief Legal Officer]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.mineralystx.com/news-events/press-releases/detail/96/mineralys-therapeutics-appoints-jeffrey-a-munsie-as-chief</link>
                <pubDate>Tue, 24 Mar 26 08:00:00 -0400</pubDate>
                <guid>https://ir.mineralystx.com/news-events/press-releases/detail/96/mineralys-therapeutics-appoints-jeffrey-a-munsie-as-chief</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.mineralystx.com/news-events/press-releases/detail/95/mineralys-therapeutics-reports-inducement-awards-under</link>
                <pubDate>Mon, 16 Mar 26 16:05:00 -0400</pubDate>
                <guid>https://ir.mineralystx.com/news-events/press-releases/detail/95/mineralys-therapeutics-reports-inducement-awards-under</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Mineralys Therapeutics Reports Fourth Quarter 2025 Financial Results and Provides Corporate Update]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.mineralystx.com/news-events/press-releases/detail/94/mineralys-therapeutics-reports-fourth-quarter-2025</link>
                <pubDate>Thu, 12 Mar 26 16:05:00 -0400</pubDate>
                <guid>https://ir.mineralystx.com/news-events/press-releases/detail/94/mineralys-therapeutics-reports-fourth-quarter-2025</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Mineralys Therapeutics Announces FDA Acceptance of NDA for Lorundrostat for Treatment of Adults with Hypertension and Topline Explore-OSA Trial Results]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.mineralystx.com/news-events/press-releases/detail/93/mineralys-therapeutics-announces-fda-acceptance-of-nda-for</link>
                <pubDate>Mon, 09 Mar 26 16:30:00 -0400</pubDate>
                <guid>https://ir.mineralystx.com/news-events/press-releases/detail/93/mineralys-therapeutics-announces-fda-acceptance-of-nda-for</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on Thursday, March 12, 2026]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.mineralystx.com/news-events/press-releases/detail/92/mineralys-therapeutics-to-announce-fourth-quarter-and-full</link>
                <pubDate>Mon, 09 Mar 26 08:00:00 -0400</pubDate>
                <guid>https://ir.mineralystx.com/news-events/press-releases/detail/92/mineralys-therapeutics-to-announce-fourth-quarter-and-full</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.mineralystx.com/news-events/press-releases/detail/91/mineralys-therapeutics-reports-inducement-awards-under</link>
                <pubDate>Thu, 26 Feb 26 16:05:00 -0500</pubDate>
                <guid>https://ir.mineralystx.com/news-events/press-releases/detail/91/mineralys-therapeutics-reports-inducement-awards-under</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.mineralystx.com/news-events/press-releases/detail/90/mineralys-therapeutics-reports-inducement-awards-under</link>
                <pubDate>Wed, 11 Feb 26 19:00:00 -0500</pubDate>
                <guid>https://ir.mineralystx.com/news-events/press-releases/detail/90/mineralys-therapeutics-reports-inducement-awards-under</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Mineralys Therapeutics Provides Corporate Update and Announces Participation in Upcoming LifeSci Partners Corporate Access Event in January 2026]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.mineralystx.com/news-events/press-releases/detail/89/mineralys-therapeutics-provides-corporate-update-and</link>
                <pubDate>Tue, 06 Jan 26 08:00:00 -0500</pubDate>
                <guid>https://ir.mineralystx.com/news-events/press-releases/detail/89/mineralys-therapeutics-provides-corporate-update-and</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Mineralys Therapeutics’ Phase 3 Launch-HTN Trial of Lorundrostat Recognized in Inaugural Journal of the American Medical Association (JAMA) “Research of the Year” Roundup]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.mineralystx.com/news-events/press-releases/detail/88/mineralys-therapeutics-phase-3-launch-htn-trial-of</link>
                <pubDate>Fri, 12 Dec 25 11:00:00 -0500</pubDate>
                <guid>https://ir.mineralystx.com/news-events/press-releases/detail/88/mineralys-therapeutics-phase-3-launch-htn-trial-of</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Mineralys Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.mineralystx.com/news-events/press-releases/detail/87/mineralys-therapeutics-reports-inducement-award-under</link>
                <pubDate>Wed, 26 Nov 25 16:05:00 -0500</pubDate>
                <guid>https://ir.mineralystx.com/news-events/press-releases/detail/87/mineralys-therapeutics-reports-inducement-award-under</guid>
                                                                            </item>
            </channel>
</rss>